ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

iPS clinical research to tackle time, cost hurdles

TOKYO -- The collaboration on clinical research announced Monday by Kyoto University and three other Japanese institutions is aimed at establishing a faster and cheaper method of using induced pluripotent stem cells for transplants while ensuring the safety of one of the most promising medical treatments.

One major advantage of using iPS cells, which can be taken from the patient and grown into necessary tissue, was originally seen as their low risk of rejection. But it takes about a year to develop iPS cells into needed tissues, which may frustrate timely treatment. The process also costs nearly 100 million yen ($931,000).

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more